Search & Analyze
Popular Searches
Suven Life Sciences Ltd.
Healthcare₹316.000.28%
24 Jul, 4:01 PM
CMP₹316.00
Mkt Cap₹8.96K Cr
P/E0.00
P/B10.64
ROE-84.88%
52W High₹371.00
52W Low₹124.35
Customise metrics bar
Stock DNA
Key Ratios
P/B Ratio
10.64
EV/EBITDA
-31.85
Price/Sales
1258.72
Dividend Yield (%)
0.00
EPS (TTM ₹)
-9.78
Book Value (₹)
29.79
ROE (%)
-84.88
ROCE (%)
-84.51
ROA (%)
-76.53
EBITDA Margin (%)
-2488.86
Net Profit Margin (%)
-2415.11
Debt/Equity
0.00
Current Ratio
3.21
Interest Coverage
-964.44
Asset Turnover
0.03
Working Capital/Sales
0.13
Core EBITDA Growth (%)
-44.99
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 1347.83 | 1184.43 | 1353.92 | 1169.3 | 665.58 |
| Net Sales | 1347.83 | 1184.43 | 1353.92 | 1169.3 | 665.58 |
| Total Income | 2123.2 | 1344.56 | 2198.82 | 3282.3 | 1755.27 |
| Total Expenditure | 9341.9 | 13409.3 | 13930.11 | 13955.77 | 17230.95 |
| Operating Profit | -7218.7 | -12064.74 | -11731.29 | -10673.47 | -15475.68 |
| Depreciation | 434.62 | 439.31 | 654.31 | 650.21 | 582.17 |
| Exceptional Items | — | 371.57 | 600 | 745.66 | — |
| Profit Before Tax | -7747.4 | -12199.51 | -11826.78 | -10607.87 | -16074.5 |
| Tax | -532.28 | — | — | -100.24 | — |
| Profit After Tax (PAT) | -7215.12 | -12199.51 | -11826.78 | -10507.63 | -16074.5 |
| EPS (₹) | -5.67 | -9.05 | -6.63 | -4.82 | -7.37 |
| Dividend Payout % | — | — | — | — | — |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 1272.82 | 1453.82 | 2180.74 | 2180.74 | 2180.74 |
| Reserves | 5835.75 | 8160.72 | 35351.2 | 24823.32 | 8690.49 |
| Shareholders Funds | 10800.57 | 9614.54 | 37531.94 | 27004.06 | 10998.68 |
| Total Debt | 133.65 | 48.43 | 0 | 0 | 0 |
| Total Liabilities | 22231.5 | 20193.16 | 48280.77 | 28490.28 | 13518.33 |
| Total Assets | 22231.5 | 20193.16 | 48280.77 | 28490.28 | 13518.33 |
| Book Value / Share | 5.5849 | 6.6133 | 17.2106 | 12.383 | 4.9851 |
| Assets | 22231.5 | 20193.16 | 48280.77 | 28490.28 | 13518.33 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | -9602.36 | -12753.7 | -11598.11 | -11546.91 | -15410.46 |
| Investing Activities | 5584.05 | -2222.92 | -24781.25 | 9443.63 | 15495.4 |
| Financing Activities | 3485.56 | 14569.16 | 39553.91 | -105.4 | -75.63 |
| Net Cash Flow | -532.75 | -407.46 | 3174.55 | -2208.68 | 9.31 |
SUVEN
₹316.00
-0.28%